Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: A case report

被引:5
作者
Carulli G. [1 ]
Marini A. [2 ]
Ciancia E.M. [3 ]
Bruno J. [4 ]
Vignati S. [3 ]
Lambelet P. [5 ]
Cannizzo E. [1 ]
Ottaviano V. [1 ]
Galimberti S. [1 ]
Caracciolo F. [1 ]
Ferreri M.I. [6 ]
Ciabatti E. [1 ]
Petrini M. [1 ]
机构
[1] Department of Oncology, Transplants and New Technologies in Medicine, Division of Hematology and Section of Flow Cytometry, University of Pisa, Pisa
[2] Laboratory of Clinical Pathology, Versilia Hospital, Lido di Camaiore
[3] Division of Pathology 2, AOUP, Pisa
[4] Division of Pathology, Versilia Hospital, Lido di Camaiore
[5] Division of Medicine, Versilia Hospital, Lido di Camaiore
[6] Laboratory of Cytogenetics, AOUP, Santa Chiara Hospital
关键词
Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Bone Marrow Infiltration; Splenic Marginal Zone Lymphoma;
D O I
10.1186/1752-1947-5-476
中图分类号
学科分类号
摘要
Introduction. Discordant lymphomas are rare entities characterized by the simultaneous presence of two distinct types of lymphomas in different anatomic sites. We describe a very rare case of simultaneous occurrence of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood. Case presentation. We report the case of a 60-year-old asymptomatic Caucasian woman in whom discordant lymphomas were discovered when a slight lymphocytosis and a conspicuous splenomegaly were observed. The different morphological, immunophenotypical and immunohistochemical features found in the different pathologic samples obtained from peripheral blood, bone marrow and spleen sections made it possible to differentiate two types of non-Hodgkin B-cell lymphomas: a mantle cell lymphoma infiltrating the spleen and a marginal zone lymphoma involving both the bone marrow and peripheral blood. Since a similar IgH gene rearrangement was found both in the bone marrow and in the spleen, the hypothesis of a common origin, followed by a different clonal selection of the neoplastic lymphocytes may be taken into consideration. Conclusion: Our case emphasizes the usefulness of investigating simultaneous specimens from different anatomic sites from the same patient and the relevant diagnostic role of splenectomy. © 2011Carulli et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 17 条
[1]  
Moktar N.M., Review Article. Composite Lymphoma, J Egypt Nalt Canc Inst, 19, pp. 171-175, (2007)
[2]  
Galimberti S., Brizzi F., Mameli M., Petrini M., An advantageous method to evaluate IgH rearrangement and its role in minimal residual disease detection, Leukemia Research, 23, 10, pp. 921-929, (1999)
[3]  
Van Dongen J.J.M., Langerak A.W., Bruggemann M., Evans P.A.S., Hummel M., Lavender F.L., Delabesse E., Davi F., Schuuring E., Garcia-Sanz R., Van Krieken J.H.J.M., Droese J., Gonzalez D., Bastard C., White H.E., Spaargaren M., Gonzalez M., Parreira A., Smith J.L., Morgan G.J., Kneba M., Macintyre E.A., Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 conc
[4]  
Lefebvre C., Fabre B., Vettier C., Rabin L., Florin A., Wang J., Gressin R., Jacob M.-C., Callanan M., Leroux D., Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones, Human Pathology, 38, 4, pp. 660-667, (2007)
[5]  
Goteri G., Rupoli S., Stramazzotti D., Discepoli G., Scortechini A.R., Giacchetti A., Morichetti D., Tassetti A., Pulini S., Mulattieri S., Stronati A., Leoni P., Coexistence of two discordant B-cell lymphomas in the skin and lymph node: Report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma [14], British Journal of Dermatology, 157, 3, pp. 629-631, (2007)
[6]  
Thieblemont C., Non-MALT marginal zone lymphomas, Ann Oncol, 19, (2008)
[7]  
Dong H.Y., Weisberger J., Liu Z., Tugulea S., Immunophenotypic analysis of CD103+ lymphoproliferative disorders, Am J Clin Pathol, 131, pp. 586-595, (2009)
[8]  
Pileri S., Falini B., Mantle cell lymphoma, Haematologica, 94, pp. 1488-1492, (2009)
[9]  
Bosch F., Lopez-Guillermo A., Campo E., Ribera J.M., Conde E., Piris M.A., Vallespi T., Woessner S., Montserrat E., Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors, Cancer, 82, 3, pp. 567-575, (1998)
[10]  
Angelopoulou M.K., Siakantariz M.P., Vassilakopoulos T.P., Kontopidou F.N., Rassidakis G.Z., Dimopoulou M.N., Kittas C., Pangalis G.A., The splenic form of mantle cell lymphoma, European Journal of Haematology, 68, 1, pp. 12-21, (2002)